Unverified50% confidenceBenchmarkExact time
In prostate cancer prediction on MSK-CHORD, the LLM's cMAE was lower than that of the RSF.
1
Sources
50%
Confidence
Long-term
Relevance
10/1/2026
First Seen
Sources
Related Entities
Related Claims
UnverifiedThe probability that a candidate drug entering Phase I clinical trials ultimately receives approval is less than 10%, and in oncology it is even lower, at approximately 5%.59% similarUnverified肿瘤局部pH值下降至约6.5-6.8，正常组织约7.456% similarUnverifiedMultiple studies have indicated that the incidence of melanoma among crew members is significantly higher than in the general population.55% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/964033API
curl https://kongchang.com/api/v1/knowledge/claims/964033MCP
get_claim(id=964033)